PharmEasy gets $300 million booster shot for Thyrocare deal
US private equity major TPG, Singapore’s Temasek, Facebook cofounder Eduardo Saverin’s B Capital, Prosus (previously Naspers) and Think Investments participated in the funding round along with a new investor — Kotak Group’s private equity arm, according to Siddharth Shah, chief executive of API Holdings, the parent company of PharmEasy.from Markets-Economic Times https://ift.tt/2Tcf8zZ
Post a Comment